Paper32731386
Repurposing Drugs to Fight Hepatic Malaria Parasites.
Fontinha D and 2 others. Molecules, 2020. Cited by 18 papers, by iCite.
Cite this record
ConductScience Library. Repurposing Drugs to Fight Hepatic Malaria Parasites. Papers, record 32731386. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32731386
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antimalarials | Major topic |
| Drug Repositioning | Major topic |
| Liver | Major topic |
| Malaria | Major topic |
| Plasmodium | Major topic |
| Animals | |
| Humans |
Source PubMed
References227
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15286734 | Drug repositioning: identifying and developing new uses for existing drugs. | Nat Rev Drug Discov | 2004 | https://conductscience.org/library/papers/15286734 | PubMed |
| 2 | 3112767 | Cytostatic effect of DL-alpha-difluoromethylornithine against Plasmodium falciparum and its reversal by diamines and spermidine. | Parasitol Res | 1987 | https://conductscience.org/library/papers/3112767 | PubMed |
| 3 | 27249674 | Current therapies and future possibilities for drug development against liver-stage malaria. | J Clin Invest | 2016 | https://conductscience.org/library/papers/27249674 | PubMed |
| 4 | 8521742 | Malaria therapy and prophylaxis with cotrifazid, a multiple complex combination consisting of rifampicin + isoniazid + sulfamethoxazole + trimethoprim. | Chemotherapy | 1995 | https://conductscience.org/library/papers/8521742 | PubMed |
| 5 | 19840874 | Malaria: targeting parasite and host cell kinomes. | Biochim Biophys Acta | 2010 | https://conductscience.org/library/papers/19840874 | PubMed |
| 6 | 20338054 | Does treatment of intestinal helminth infections influence malaria? Background and methodology of a longitudinal study of clinical, parasitological and immunological parameters in Nangapanda, Flores, Indonesia (ImmunoSPIN Study). | BMC Infect Dis | 2010 | https://conductscience.org/library/papers/20338054 | PubMed |
| 7 | 15980379 | Antimalarial activity of human immunodeficiency virus type 1 protease inhibitors. | Antimicrob Agents Chemother | 2005 | https://conductscience.org/library/papers/15980379 | PubMed |
| 8 | 25414261 | Ivermectin as a complementary strategy to kill mosquitoes and stop malaria transmission? | Clin Infect Dis | 2015 | https://conductscience.org/library/papers/25414261 | PubMed |
| 9 | 20133198 | Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination. | Trends Parasitol | 2010 | https://conductscience.org/library/papers/20133198 | PubMed |
| 10 | 6413237 | Plasmodium berghei: inhibition of the sporogonous cycle by alpha-difluoromethylornithine. | Exp Parasitol | 1983 | https://conductscience.org/library/papers/6413237 | PubMed |
| 11 | 1949136 | Sensitivity of Plasmodium falciparum in The Gambia to co-trimoxazole. | Trans R Soc Trop Med Hyg | 1991 | https://conductscience.org/library/papers/1949136 | PubMed |
| 12 | 3105475 | alpha-Difluoromethylornithine inhibits the first part of exoerythrocytic schizogony of Plasmodium berghei in rodents. | Ann Soc Belg Med Trop | 1986 | https://conductscience.org/library/papers/3105475 | PubMed |
| 13 | 16267125 | Purinoceptors are involved in the induction of an osmolyte permeability in malaria-infected and oxidized human erythrocytes. | FASEB J | 2006 | https://conductscience.org/library/papers/16267125 | PubMed |
| 14 | 1981663 | The chemotherapy of rodent malaria. XLV. Reversal of chloroquine resistance in rodent and human Plasmodium by antihistaminic agents. | Ann Trop Med Parasitol | 1990 | https://conductscience.org/library/papers/1981663 | PubMed |
| 15 | 3097887 | alpha-Difluoromethylornithine induces protective immunity in mice inoculated with Plasmodium berghei sporozoites. | Trans R Soc Trop Med Hyg | 1986 | https://conductscience.org/library/papers/3097887 | PubMed |
| 16 | 30067811 | Deciphering the targets of retroviral protease inhibitors in Plasmodium berghei. | PLoS One | 2018 | https://conductscience.org/library/papers/30067811 | PubMed |
| 17 | 12956942 | Antimalarial effect of agmatine on Plasmodium berghei K173 strain. | Acta Pharmacol Sin | 2003 | https://conductscience.org/library/papers/12956942 | PubMed |
| 18 | 18443130 | Stronger activity of human immunodeficiency virus type 1 protease inhibitors against clinical isolates of Plasmodium vivax than against those of P. falciparum. | Antimicrob Agents Chemother | 2008 | https://conductscience.org/library/papers/18443130 | PubMed |
| 19 | 17413699 | Antimalarial activity of sera from subjects taking HIV protease inhibitors. | AIDS | 2007 | https://conductscience.org/library/papers/17413699 | PubMed |
| 20 | 15776390 | Aspartic proteases of Plasmodium falciparum as the target of HIV-1 protease inhibitors. | J Infect Dis | 2005 | https://conductscience.org/library/papers/15776390 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40814068 | The emerging role of Imatinib in malaria management: a review of evidence and future directions. | Trop Dis Travel Med Vaccines | 2025 | https://conductscience.org/library/papers/40814068 | PubMed |
| 40278767 | Combating Malaria: Targeting the Ubiquitin-Proteasome System to Conquer Drug Resistance. | Trop Med Infect Dis | 2025 | https://conductscience.org/library/papers/40278767 | PubMed |
| 39896318 | Exploration of innovative drug repurposing strategies for combating human protozoan diseases: Advances, challenges, and opportunities. | J Pharm Anal | 2025 | https://conductscience.org/library/papers/39896318 | PubMed |
| 39810526 | Targeting Malaria's Achilles' Heels: A Review of Plasmodium Life Cycle Vulnerabilities for Drug Discovery. | Curr Top Med Chem | 2025 | https://conductscience.org/library/papers/39810526 | PubMed |
| 39505355 | Antiplasmodial and Insecticidal Activities of Third-Generation Ivermectin Hybrids. | J Med Chem | 2024 | https://conductscience.org/library/papers/39505355 | PubMed |
| 39352879 | Repositioning Brusatol as a Transmission Blocker of Malaria Parasites. | ACS Infect Dis | 2024 | https://conductscience.org/library/papers/39352879 | PubMed |
| 38639491 | Novel hydrazone compounds with broad-spectrum antiplasmodial activity and synergistic interactions with antimalarial drugs. | Antimicrob Agents Chemother | 2024 | https://conductscience.org/library/papers/38639491 | PubMed |
| 36986868 | Derivatives of Amaryllidaceae Alkaloid Ambelline as Selective Inhibitors of Hepatic Stage of Plasmodium berghei Infection In Vitro. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/36986868 | PubMed |
| 36960081 | Drug Development Strategies for Malaria: With the Hope for New Antimalarial Drug Discovery-An Update. | Adv Med | 2023 | https://conductscience.org/library/papers/36960081 | PubMed |
| 36169491 | In vitro and in silico assessment of new beta amino ketones with antiplasmodial activity. | Rev Soc Bras Med Trop | 2022 | https://conductscience.org/library/papers/36169491 | PubMed |
| 36118020 | Structural insights into Plasmodium PPIases. | Front Cell Infect Microbiol | 2022 | https://conductscience.org/library/papers/36118020 | PubMed |
| 34832911 | Studies of Potency and Efficacy of an Optimized Artemisinin-Quinoline Hybrid against Multiple Stages of the Plasmodium Life Cycle. | Pharmaceuticals (Basel) | 2021 | https://conductscience.org/library/papers/34832911 | PubMed |
| 33921170 | Drug Repurposing: A Review of Old and New Antibiotics for the Treatment of Malaria: Identifying Antibiotics with a Fast Onset of Antiplasmodial Action. | Molecules | 2021 | https://conductscience.org/library/papers/33921170 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| DHFR | 1719 | PubTator's text mining | https://conductscience.org/library/genes/1719 | NCBI Gene |
| MARVELD2 | 153562 | PubTator's text mining | https://conductscience.org/library/genes/153562 | NCBI Gene |
| ODC1 | 4953 | PubTator's text mining | https://conductscience.org/library/genes/4953 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32731386
GET https://conductscience.org/api/papers/v1/32731386/references?page=2